Together, with epithelial cells, IL-1α expressing endothelium could explain positive outcome of anakinra (IL-1 receptor antagonist) in a subgroup of COVID-19 patients [10], and specifically IL-1α blockade in animal model of COVID-19 [42]. Here, IL1A is linked to COVID-19.